Hemophilia B Treatment Market
Hemophilia B Treatment Market Analysis, By Treatment Type (Recombinant Factor IX Concentrates, Plasma-Derived Factor IX Concentrates, Gene Therapy, and Extended Half-Life Factor IX) By Patient Demographics (Pediatrics and Adults) By Severity of Hemophilia B (Mild Hemophilia B, Moderate Hemophilia B, and Severe Hemophilia B) By Distribution Channel (Hospitals, Specialty Clinics, and Online Pharmacies), and Region - Market Insights 2024 to 2034
Analysis of Hemophilia B Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT10411MR
- 30 Sep 2024
- Healthcare
- 170 Pages
- 40 Tables
- 40 Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Treatment Type
- 5.2. Patient Demographics
- 5.3. Severity of Hemophilia B
- 5.4. Distribution Channel
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment Type
- 6.1. Recombinant Factor IX Concentrates
- 6.2. Plasma-Derived Factor IX Concentrates
- 6.3. Gene Therapy
- 6.4. Extended Half-Life Factor IX
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Demographics
- 7.1. Pediatrics
- 7.2. Adults
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Severity of Hemophilia B
- 8.1. Mild Hemophilia B
- 8.2. Moderate Hemophilia B
- 8.3. Severe Hemophilia B
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 9.1. Hospitals
- 9.2. Specialty Clinics
- 9.3. Online Pharmacies
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Sales Forecast 2024 to 2034 by Treatment Type, Patient Demographics, Severity of Hemophilia B, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. uniQure (CSL Behring)
- 20.2. Pfizer
- 20.3. Hoffmann-La Roche Ltd
- 20.4. Octapharma
- 20.5. Sanofi
- 20.6. Bayer AG
- 20.7. Baxter
- 20.8. Swedish Orphan Biovitrum AB
- 20.9. Grifols International S.A
- 20.10. Kedrion Biopharma, Inc.
- 20.11. Biomarin Pharmaceutical, Inc.
- 20.12. Chugai Pharmaceutical
- 20.13. Biogen, Inc.
List Of Table
Table 1: Global Market US$ Mn & Unit Forecast by Region, 2019 to 2034
Table 2: Global Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 3: Global Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 4: Global Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 5: Global Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 6: North America Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 7: North America Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 8: North America Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 9: North America Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 10: North America Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 11: Latin America Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 12: Latin America Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 13: Latin America Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 14: Latin America Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 15: Latin America Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 16: Western Europe Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 17: Western Europe Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 18: Western Europe Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 19: Western Europe Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 20: Western Europe Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 21: Eastern Europe Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 22: Eastern Europe Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 23: Eastern Europe Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 24: Eastern Europe Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 25: Eastern Europe Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 26: East Asia Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 27: East Asia Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 28: East Asia Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 29: East Asia Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 30: East Asia Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 31: South Asia & Pacific Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 32: South Asia & Pacific Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 33: South Asia & Pacific Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 34: South Asia & Pacific Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 35: South Asia & Pacific Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 36: MEA Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 37: MEA Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 38: MEA Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 39: MEA Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 40: MEA Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Region, 2019 to 2034
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 29: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 30: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 31: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 32: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 33: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 34: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 35: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Hemophilia B Treatment Market